Fudan University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer
- Conditions
- Colorectal Neoplasms
- Interventions
- Procedure: Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDRProcedure: surgery
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 600
- Registration Number
- NCT00643877
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, China
Study of Apatinib as an Inhibitor of Tumor Angiogenesis
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 18
- Registration Number
- NCT00633490
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)
- Conditions
- Breast CancerMetastasis, Neoplasm
- Interventions
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00629148
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease
- Conditions
- Parkinson Disease
- Interventions
- Drug: Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)Drug: placebo
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2010-05-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 144
- Registration Number
- NCT00629161
- Locations
- 🇨🇳
Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
🇨🇳Zhongshan hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences, Beijing, Beijing, China
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
- First Posted Date
- 2008-01-25
- Last Posted Date
- 2011-07-04
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 70
- Registration Number
- NCT00601159
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer
- Conditions
- Gastric Cancer
- Interventions
- Drug: ECF-endostar
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT00595972
- Locations
- 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China
Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2009-07-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 5
- Registration Number
- NCT00595985
- Locations
- 🇨🇳
Fudan University Cancer Hospital, ShangHai, Shanghai, China
An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2008-04-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT00589901
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Study of Weekly DCF to Treat Advanced Gastric Cancer
- Conditions
- Gastric Cancer
- Interventions
- Drug: Docetaxel, Cisplatin, 5-Fu
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2010-01-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT00568971
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 31
- Registration Number
- NCT00568815
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China